MaRS Innovation's President and CEO, Dr. Raphael (Rafi) Hofstein, was appointed to the Quebec Consortium for Drug Discovery (CQDM) Board of Directors on February 18.
CQDM is a Quebec-based not-for profit that funds and supports joint projects in private and biopharmaceutical sectors.
Here's an excerpt from CQDM's announcement:
Dr. Hofstein, actively involved in the field of biotechnology, partnerships and technology transfer for over 30 years, greatly contributed to defining Israel as a world leader in biotechnology. In Israel, Dr. Hofstein held various positions including R & D Manager ...